http://purl.org/np/RANPwU8K1KUcINyr6ByFvcFD5ipe75jxxg7Q909h63gn0
.trig | .trig.txt | .jelly | .jelly.txt | .jsonld | .jsonld.txt | .nq | .nq.txt | .xml | .xml.txt
@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RANPwU8K1KUcINyr6ByFvcFD5ipe75jxxg7Q909h63gn0> .
@prefix sub: <http://purl.org/np/RANPwU8K1KUcINyr6ByFvcFD5ipe75jxxg7Q909h63gn0#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:3uitj0kw&rows=> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
<https://uts.nlm.nih.gov/uts/umls/concept/C0015133> ns1:treat <https://uts.nlm.nih.gov/uts/umls/concept/C0087111> .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T20:03:20.922962"^^xsd:dateTime;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value "2"^^xsd:integer .
rdf:OBJECT rdfs:label "hemophagocytic lymphohistiocytosis ( NK)/T-LAHLH ), a rare and fatal disease with no effective therapy" .
rdf:OBJECT-POSITION rdfs:label "94"^^xsd:integer .
rdf:PREDICATE rdfs:label "treating" .
rdf:PREDICATE-POSITION rdfs:label "[95]" .
rdf:SUBJECT rdfs:label "etoposide + dexamethasone-based chemotherapy regimens" .
rdf:SUBJECT-POSITION rdfs:label "21"^^xsd:integer .
rdfs:ABSTRACT-UID ns2:50 "3uitj0kw" .
rdfs:SENTENCE rdfs:label "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy." .
rdfs:TRIPLE-UID ns3:3uitj0kw-TRIPLE-ABSTRACT-4 "3uitj0kw-TRIPLE-ABSTRACT-4" .
<https://uts.nlm.nih.gov/uts/umls/concept/C0015133> rdfs:label "etoposide" .
<https://uts.nlm.nih.gov/uts/umls/concept/C0087111> rdfs:label "therapy" .
}
sub:pubInfo {
sub:assertion prov:wasDerivedFrom <https://doi.org/10.1007/s00432-020-03376-7> .
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "VwfgAXdWAa1doQa8CBw69FwCijajV/Z2Km9YI/Iti7D2R23Tyy3/7w7PAzljTUDMXKZVtdxbeERD/Ie5O4kzzekw7XUOdDoWE0Pi0q2tx4vA6ONNpv0bm2HkOMd9DldvpjwG2+lW5ZW4orbaEkhfrVOAO4stThB9KFvlNKWeRyo=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-12-16T20:03:20.922962"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}